Previous 10 | Next 10 |
Tiziana Life Sciences PLC (NASDAQ: TLSA ) +162% on potential coronavirus treatment . More news on: Tiziana Life Sciences PLC, Phio Pharmaceuticals Corp., Inovio Pharmaceuticals, Inc., Stocks on the move, , Read more ...
Spherix (NASDAQ: SPEX ) +72% . More news on: Spherix Incorporated, AIM ImmunoTech Inc., Cocrystal Pharma, Inc., Stocks on the move, , Read more ...
Nes-Ziona, March 09, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics, Ltd., a clinical-stage immunotherapy company, today announced that the Israel Patent Office granted a new patent (#239236) covering ALLOCETRA TM , the company’s immunotherapy candidate. This new patent adds intellect...
Point Roberts, WA and Delta, BC - February 28, 2020 (Investorideas.com Newswire) Investorideas.com , a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories in biotech, retail, real estate, sports, food & beverage (rest...
Nes-Ziona, Israel, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced the closing of its previously announced registered direct offering to certain institutional investors of 1,000,000 ordinary shares of t...
Nes-Ziona, Israel, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that it has entered into definitive agreements with certain institutional investors for the purchase in a registered direct offering of...
NGM Biopharmaceuticals (NASDAQ: NGM ) +67% after aldafermin phase 2 results . More news on: NGM Biopharmaceuticals, Inc., NanoViricides, Inc., Enlivex Therapeutics Ltd., Stocks on the move, , Read more ...
Enlivex Therapeutics (NASDAQ: ENLV ) announces plan to start increasing the manufacturing capacity of Allocetra after the first confirmed coronavirus case in Israel. More news on: Enlivex Therapeutics Ltd., Healthcare stocks news, Stocks on the move, Read more ...
Nes-Ziona, Israel, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that it is initiating a plan to increase its manufacturing capacity of Allocetra TM , following the first confirmed coronavirus (COVID-19...
Nes-Ziona, Israel, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the company was selected, for a scientific presentation of two posters: (i) Allocetra-OTS: Early Apoptotic Cells for Immune Hom...
News, Short Squeeze, Breakout and More Instantly...
Enlivex Therapeutics Ltd. Company Name:
ENLV Stock Symbol:
NASDAQ Market:
Enlivex Therapeutics Ltd. Website:
• First study of Allocetra TM in psoriatic arthritis, a chronic inflammatory condition that causes joint pain, swelling and stiffness, affects as many as 30% of people with psoriasis 1 , and has limited treatment options Nes-Ziona, Israel, July 23, 2024 (GLOB...
ORLANDO, FL / ACCESSWIRE / July 19, 2024 / RedChip Companies will air interviews with Enlivex Therapeutics Ltd. (Nasdaq:ENLV) and Biotricity, Inc. (Nasdaq:BTCY) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, July 20, at 7 p.m. Eastern T...
First patient dosed with Allocetra TM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of people Thumb osteoarthritis currently has no FDA-approved therapy and no effective long-term treatments Ness-Ziona, Israel, June 24, 2024 (GLO...